A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
Status:
Recruiting
Trial end date:
2024-03-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate MEDI5752 in adult subjects with advanced solid
tumors, when administered as a single agent or combined with chemotherapy.